Instalab

Egg White (Gal d 1) IgE Test Blood

The clearest read on whether an egg allergy will stick around or fade, and whether baked egg is safe to try.

Should you take a Egg White (Gal d 1) IgE test?

This test is most useful if any of these apply to you.

Parents of a Child With Egg Allergy
If your child has been diagnosed, this test helps you understand whether baked egg might be tolerated and how likely the allergy is to fade.
Sorting Out a Suspected Egg Reaction
If your child reacted after eating egg, this test adds clarity about whether the reaction was a true allergy and how cautious to be with cooked egg.
Tracking Whether an Allergy Is Fading
If you are monitoring an established egg allergy, repeat testing shows whether the immune response is loosening and tolerance is developing.
Considering Oral Immunotherapy
If you are weighing egg desensitization, a baseline reading helps gauge the starting point and predict the likelihood of sustained tolerance.

About Egg White (Gal d 1) IgE

Among the hundreds of proteins in an egg, one is the troublemaker that keeps a true egg allergy intact even after the egg is baked into a cake. That protein is called Gal d 1, or ovomucoid. The IgE (immunoglobulin E, the antibody class that drives immediate allergic reactions) your body makes against Gal d 1 is one of the best available lab signals for predicting whether someone will react to heated and baked egg, and whether the allergy is going to fade with age or persist.

Standard egg white testing tells you whether the immune system has reacted to egg in general. This test answers a more useful question: is the reaction the kind that survives an oven? That answer shapes real decisions, like whether a child can safely eat a muffin at a birthday party, when to try reintroducing egg, and how long avoidance is likely to last.

What This Test Actually Measures

Egg white contains several allergenic proteins, but ovomucoid (Gal d 1) is the one that resists both heat and stomach digestion. That stability is why people who are sensitized to Gal d 1 tend to react not only to scrambled eggs but also to baked goods that contain egg. The blood test counts IgE antibodies in serum that specifically bind to this single protein, reported in units called kU/L (a measure of antibody concentration, where higher numbers mean more antibody is circulating).

This is a more focused look than a whole egg white IgE test. Egg white IgE picks up antibodies against any allergenic protein in the egg, including some that fall apart with cooking. Gal d 1 IgE zeroes in on the protein that most predicts trouble with the cooked egg most people actually eat.

Predicting Reactions to Heated and Baked Egg

This is where Gal d 1 testing is most useful. In a study of 185 Finnish children and adolescents, Gal d 1 IgE predicted reactions to heated egg with high accuracy, catching about 78 out of 100 true reactors while correctly clearing 95 out of 100 non-reactors at a chosen threshold. Children with very high values (above roughly 14 kU/L in that cohort) reacted to heated egg in essentially every challenge, while children with values below about 0.9 kU/L passed challenges about 95% of the time.

A Japanese cohort of 108 egg-allergic children found similar patterns: ovomucoid IgE was more useful than whole egg white IgE for predicting reactivity to heat-treated egg. A microarray study of 68 children reported that those positive for Gal d 1 reacted to raw egg about 95% of the time, while those negative for Gal d 1 tolerated boiled egg about 94% of the time.

Who Was StudiedWhat Was ComparedWhat They Found
185 Finnish children and adolescentsGal d 1 IgE versus heated egg food challengeAt a study-derived threshold, the test caught about 78 out of 100 reactors and correctly cleared 95 out of 100 non-reactors
108 Japanese egg-allergic childrenOvomucoid IgE versus whole egg white IgEOvomucoid was better for predicting heated egg reactions; whole egg white was better for raw egg
68 children with suspected egg allergyGal d 1 positive versus Gal d 1 negativeGal d 1 positive children reacted to raw egg about 95% of the time; Gal d 1 negative children tolerated boiled egg about 94% of the time

What this means for you: a high Gal d 1 value gives strong reason to keep avoiding even baked egg until reactivity drops, while a very low value adds confidence (though not certainty) that a supervised baked-egg trial may be reasonable. Oral food challenge under medical supervision remains the only definitive answer.

Whether the Allergy Will Persist or Resolve

Most egg allergies in young children eventually resolve, but not all of them, and not on the same timeline. Gal d 1 testing helps separate the two paths. In a population study of 451 infants in the HealthNuts cohort, being sensitized to Gal d 1 at one year of age roughly doubled the odds of persistent egg allergy at age two to four. When children were sensitized to multiple egg components at once, including Gal d 1, the odds of persistence rose about four-fold compared to children sensitized only to whole egg white.

The direction the number moves over time matters as much as a single value. In a study of 124 egg-allergic children, a drop of 30% or more in egg white IgE over twelve months was strongly associated with developing tolerance, with about 92% achieving tolerance when that reduction occurred. The trend tells you whether the immune system is loosening its grip.

Severity and Anaphylaxis Risk

Higher Gal d 1 levels track with more severe reactions. A study of 44 egg-allergic children that mapped IgE to individual pieces of the ovomucoid protein found that broader and stronger antibody binding patterns linked to more severe reactions, including anaphylaxis (a sudden, whole-body allergic reaction that can affect breathing and blood pressure). In a separate study of 51 egg-allergic patients, egg-specific IgE titers correlated with the severity of reactions during standardized challenges.

What this means for you: Gal d 1 is not a perfect severity predictor on its own, but very high values argue for extra caution. They support a conversation about carrying an epinephrine auto-injector and avoiding situations where accidental exposure could happen.

When Results Can Be Misleading

  • Cutoffs vary by population: studies in Finnish, Japanese, Korean, and Australian children have produced different thresholds for predicting clinical reactivity. A value that looks reassuring in one cohort may be borderline in another, which is why interpretation depends on the lab and population context.
  • Sensitization without allergy: a positive Gal d 1 IgE shows the immune system has produced antibodies, but it does not always mean the person will react when they eat egg. Some children with elevated values tolerate egg perfectly well, which is one reason oral food challenges remain the gold standard.
  • Negative does not equal safe: Gal d 1 IgE has high specificity but only moderate sensitivity, meaning a low number can still occur in someone who genuinely reacts. Whole egg white IgE picks up some of these missed cases, which is why the two tests are often ordered together.
  • Test variation between labs: different assay systems (ImmunoCAP, 3gAllergy, microarray) can give somewhat different numbers for the same sample. Tracking a trend is most reliable when the same lab and method are used each time.

Tracking the Trend Over Time

A single Gal d 1 reading is a snapshot. The trajectory is the movie, and it tells you far more. In egg allergy, the immune system slowly shifts as children grow, and watching the number drop is one of the strongest signs that tolerance is developing. A study of 124 children found that the rate of reduction over twelve months was an independent predictor of who would outgrow the allergy.

A reasonable cadence for someone managing an egg allergy: get a baseline reading at diagnosis, then retest at six to twelve month intervals while avoiding egg. If interventions like a baked-egg ladder or oral immunotherapy are being considered, retest before starting and again after meaningful exposure has occurred. Use the same lab each time so the numbers are directly comparable.

What to Do With an Unexpected Result

A high Gal d 1 value combined with a history of reactions does not require new action beyond continued avoidance and an action plan for accidental exposure. It does support seeing an allergist who can discuss whether oral immunotherapy or biologic therapy might be appropriate, since these options can change the underlying allergic response.

A surprisingly low Gal d 1 value, especially combined with a history of mild or outgrown-seeming reactions, is not a green light to start eating egg at home. It is a reason to schedule a supervised oral food challenge with an allergist, who can also weigh in on whether to start with baked egg, lightly cooked egg, or raw egg. A skin prick test to egg white, basophil activation test, or whole egg white IgE can add context, since each test catches different cases the others miss.

If the value sits in an in-between range with an unclear history, retest in three to six months and pair the result with skin prick testing. A consistent downward trend over multiple readings is one of the most reliable signals that tolerance is developing, and it provides the clearest case for moving forward with a supervised challenge.

What Moves This Biomarker

Evidence-backed interventions that affect your Egg White (Gal d 1) IgE level

Decrease
Oral immunotherapy (OIT) with egg
Egg oral immunotherapy gradually shifts the immune response away from reactivity, with lower baseline ovomucoid IgE associated with the best outcomes. In a randomized trial of 55 egg-allergic patients undergoing egg OIT, lower pretreatment ovomucoid IgE levels predicted sustained unresponsiveness (lasting tolerance after stopping treatment), and the procedure raised IgG4 (a protective blocking antibody) while modulating allergen-specific IgA. This is the closest thing to a disease-modifying treatment for egg allergy and works best when started while values are not extremely high.
MedicationModerate Evidence
Decrease
Regular ingestion of extensively heated (baked) egg
Children with egg allergy who tolerate and regularly eat extensively baked egg show immune changes consistent with developing tolerance, including rising IgG4 and shifts in skin prick reactivity. In a study of 117 children with egg allergy, most could tolerate heated egg, and continued ingestion produced immunologic changes similar to those seen in children who naturally outgrow the allergy. This works only in children who have first been confirmed to tolerate baked egg through a supervised challenge.
MedicationModerate Evidence
Increase
Omalizumab (anti-IgE antibody therapy)
Omalizumab binds and neutralizes circulating IgE, raising the threshold dose of allergen needed to trigger a reaction. In a randomized trial of 180 children and adults with multiple food allergies, including egg, sixteen weeks of omalizumab significantly increased the dose tolerated during food challenges versus placebo. The therapy does not consistently lower measured Gal d 1 IgE itself, but it makes the antibodies the test counts functionally less active, which is why this is labeled neutral for the lab value despite being clinically beneficial.
MedicationModerate Evidence
Decrease
Strict egg avoidance over months to years
In children who naturally outgrow egg allergy, egg white IgE tends to drift downward over time even without active treatment. In a study of 124 egg-allergic children, a drop of 30% or more in egg white IgE over twelve months was strongly associated with developing tolerance, with about 92% achieving tolerance when that reduction occurred. Avoidance alone does not actively desensitize the immune system, but it allows the natural waning of IgE production in those whose immune system is moving toward tolerance.
LifestyleModest Evidence

Frequently Asked Questions

References

12 studies
  1. Palosuo K, Kukkonen a, Pelkonen a, Mäkelä MPediatric Allergy and Immunology2018
  2. Ando H, Movérare R, Kondo Y, Tsuge I, Tanaka a, Borres M, Urisu aThe Journal of Allergy and Clinical Immunology2008
  3. Dang T, Peters R, Koplin J, Dharmage S, Gurrin L, Ponsonby a, Martino D, Neeland M, Tang M, Allen KAllergy2018
  4. Kim JD, Kim SY, Kwak EJ, Sol I, Kim MJ, Kim Y, Kim K, Sohn MAllergy, Asthma & Immunology Research2019